NO20021305L - DNA construction and its use - Google Patents

DNA construction and its use

Info

Publication number
NO20021305L
NO20021305L NO20021305A NO20021305A NO20021305L NO 20021305 L NO20021305 L NO 20021305L NO 20021305 A NO20021305 A NO 20021305A NO 20021305 A NO20021305 A NO 20021305A NO 20021305 L NO20021305 L NO 20021305L
Authority
NO
Norway
Prior art keywords
dna construction
dna
construction
Prior art date
Application number
NO20021305A
Other languages
Norwegian (no)
Other versions
NO20021305D0 (en
Inventor
Anna-Stina Hoeglund
Kjell Staalberg
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Publication of NO20021305D0 publication Critical patent/NO20021305D0/en
Publication of NO20021305L publication Critical patent/NO20021305L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0069Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/825Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
NO20021305A 1999-09-17 2002-03-15 DNA construction and its use NO20021305L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903336A SE9903336D0 (en) 1999-09-17 1999-09-17 DNA construct and its use
PCT/SE2000/001767 WO2001020011A1 (en) 1999-09-17 2000-09-13 Dna construct and its use

Publications (2)

Publication Number Publication Date
NO20021305D0 NO20021305D0 (en) 2002-03-15
NO20021305L true NO20021305L (en) 2002-05-15

Family

ID=20417035

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021305A NO20021305L (en) 1999-09-17 2002-03-15 DNA construction and its use

Country Status (7)

Country Link
EP (1) EP1212444A1 (en)
JP (1) JP2003509057A (en)
AU (1) AU7693600A (en)
CA (1) CA2382444A1 (en)
NO (1) NO20021305L (en)
SE (1) SE9903336D0 (en)
WO (1) WO2001020011A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2418155A1 (en) 2000-07-18 2002-01-24 National Research Council Of Canada Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli
CA2495235A1 (en) 2002-08-20 2004-03-04 Sungene Gmbh & Co. Kgaa Use of astaxanthin-containing plants or parts of plants of the genus tagetes as animal feed
DE10321963A1 (en) * 2003-05-15 2004-12-02 Icon Genetics Ag Process for the production of a plastid-directed protein in plant cells
AU2006227165B2 (en) 2005-03-18 2011-11-10 Microbia, Inc. Production of carotenoids in oleaginous yeast and fungi
US20070293568A1 (en) 2006-06-16 2007-12-20 Yamaha Hatsudoki Kabushiki Kaisha Neurocyte Protective Agent
EP2078092A2 (en) 2006-09-28 2009-07-15 Microbia, Inc. Production of carotenoids in oleaginous yeast and fungi
WO2011011693A1 (en) 2009-07-23 2011-01-27 Chromatin, Inc. Sorghum centromere sequences and minichromosomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618988A (en) * 1990-03-02 1997-04-08 Amoco Corporation Enhanced carotenoid accumulation in storage organs of genetically engineered plants
US5916791A (en) * 1995-11-24 1999-06-29 Hirschberg; Joseph Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a β--C--4--oxygenase activity for biotechnological production of (3S,3S)astaxanthin
BR9713462A (en) * 1996-08-09 2000-03-28 Calgene Inc Methods for producing carotenoid compounds and special oils in plant seeds.
US6429356B1 (en) * 1996-08-09 2002-08-06 Calgene Llc Methods for producing carotenoid compounds, and specialty oils in plant seeds
SE522246C2 (en) * 1997-02-27 2004-01-27 Astacarotene Ab Oral preparation for prophylactic and therapeutic treatment of Helicobacter Sp. infection
SE511237C2 (en) * 1997-12-16 1999-08-30 Astacarotene Ab Use of at least one type of xanthophyll for the preparation of a human or veterinary drug for the prophylactic treatment of mastitis in mammalian mothers

Also Published As

Publication number Publication date
EP1212444A1 (en) 2002-06-12
CA2382444A1 (en) 2001-03-22
WO2001020011A1 (en) 2001-03-22
SE9903336D0 (en) 1999-09-17
JP2003509057A (en) 2003-03-11
NO20021305D0 (en) 2002-03-15
AU7693600A (en) 2001-04-17

Similar Documents

Publication Publication Date Title
IS6411A (en) Kaspasa inhibits and their use
NO20021449D0 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
DK1122244T3 (en) Uracil compounds and their use
ID26056A (en) DIAPON ONCE USE
DK2325317T3 (en) RECEPTOR NUCLEIC ACIDS AND POLYPEPTIDR
ID26389A (en) DIAPON ONCE USE
NO20015156L (en) 5-pyridyl-1,3-azole compounds, their preparation and use
NO20014560D0 (en) Quinasolines and their therapeutic use
DE60019547D1 (en) biosensor
DE60018541D1 (en) biosensor
NO20014603L (en) Tienopyrimidine Compounds, Their Preparation and Use
NO20024355D0 (en) Nucleoside Compounds and Uses thereof
NO20021964D0 (en) Biological fluid treatment
DK1106607T3 (en) Uracil compounds and their use
IS6401A (en) Chemical methods and intermediates
DE60022034D1 (en) LAST CONSTRUCTION
ID25571A (en) DIAPON ONCE USE
ID24782A (en) DIAPON ONCE USE
NO20021305D0 (en) DNA construction and its use
NO20013085D0 (en) Phosphorus-organic compounds and their use
ID25990A (en) DNA Structure
DE29905123U1 (en) Plate-shaped element
NO20021498D0 (en) The PRV-1 gene and its use
NO20013320L (en) Detachable and switchable water connection
NO991854A (en) Farming pens and their use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application